Microplastics and Cancer: What the Latest Research Reveals

The question of whether microplastics cause cancer is one of the most urgent and consequential health questions of our time. Humans are now ingesting, inhaling, and absorbing microplastic particles on a daily basis — an estimated 5 grams per week according to a widely cited WWF-commissioned study, roughly the weight of a credit card. These particles have been found in human blood, lungs, liver, kidneys, placenta, and most recently, in brain tissue. As the body of evidence grows, researchers are increasingly investigating the link between chronic microplastic exposure and cancer risk.
It is important to state upfront that the science is still evolving. No study has yet proven a direct causal relationship between microplastic ingestion and cancer in humans. However, the emerging evidence from epidemiological studies, animal models, and cellular research paints a concerning picture that warrants serious attention. This article examines what the latest research reveals, explains the biological mechanisms through which microplastics could promote cancer, and outlines practical steps to reduce your risk.
The 2024 NEJM Study: Microplastics in Arterial Plaque and Cardiovascular/Cancer Risk
Perhaps the most significant study to date linking microplastics to serious health outcomes was published in the New England Journal of Medicine (NEJM) in March 2024. Researchers at the University of Campania Luigi Vanvitelli in Italy analyzed carotid artery plaque samples from 304 patients who underwent carotid endarterectomy, a surgical procedure to remove blockages from the arteries supplying the brain.
Using pyrolysis-gas chromatography mass spectrometry, the team found that 58.4% of patients had measurable levels of polyethylene in their arterial plaque, and 12.1% had polyvinyl chloride (PVC). Patients with microplastics detected in their arterial plaque had a 4.53 times higher risk of experiencing a composite outcome of heart attack, stroke, or death from any cause over a 34-month follow-up period compared to patients without detectable microplastics.
While the study primarily focused on cardiovascular outcomes, the researchers noted elevated inflammatory biomarkers (including interleukin-18, interleukin-1-beta, and tumor necrosis factor-alpha) in patients with microplastic-laden plaque. These same inflammatory pathways are well-established drivers of cancer development and progression. The study did not specifically track cancer outcomes, but the profound inflammatory response associated with embedded microplastics has direct implications for cancer risk through chronic inflammation — one of the recognized hallmarks of cancer biology.
This study was groundbreaking because it was the first large-scale prospective study to directly link microplastics in human tissue to hard clinical outcomes. It moved the scientific conversation from “microplastics are present in the body” to “microplastics in the body are associated with significantly worse health outcomes.”
Biological Mechanisms: How Microplastics Could Promote Cancer
Understanding how microplastics might contribute to cancer development requires examining several interconnected biological pathways. Researchers have identified at least four major mechanisms through which chronic microplastic exposure could increase cancer risk.
1. Chronic Inflammation
When microplastic particles lodge in tissues, the immune system recognizes them as foreign invaders and mounts an inflammatory response. Unlike a bacterial infection that resolves, plastic particles are not biodegradable — the body cannot break them down. This creates a state of chronic, low-grade inflammation as immune cells continuously attempt to attack and engulf the persistent foreign material.
Chronic inflammation is one of the most well-established drivers of cancer. It has been directly linked to the development of colorectal cancer, liver cancer, lung cancer, and many other malignancies. The sustained release of pro-inflammatory cytokines (IL-6, IL-1-beta, TNF-alpha) creates a tissue microenvironment that promotes DNA damage, inhibits apoptosis (programmed cell death), and stimulates angiogenesis (new blood vessel formation) — all processes that favor tumor growth.
Animal studies have confirmed this mechanism. A 2023 study published in Environmental Health Perspectives found that mice chronically exposed to polystyrene microplastics developed significant intestinal inflammation and showed precancerous changes in their colon epithelium after 12 weeks. The inflammatory markers in these mice were comparable to those seen in early-stage inflammatory bowel disease, a known risk factor for colorectal cancer in humans.
2. Oxidative Stress and DNA Damage
Microplastics generate reactive oxygen species (ROS) when they interact with cellular machinery. ROS are highly reactive molecules that can directly damage DNA, causing mutations that may lead to uncontrolled cell growth — the fundamental mechanism of cancer. Studies on human cell cultures have shown that exposure to polystyrene and polyethylene microplastics increases intracellular ROS levels by 200 to 400% compared to unexposed cells.
A 2022 study from Nanjing Medical University demonstrated that nanoplastic particles (smaller than 1 micrometer) can penetrate cell nuclei and directly interfere with DNA repair mechanisms. When cells lose their ability to repair DNA damage, mutations accumulate at an accelerated rate. This process, known as genomic instability, is a hallmark of cancer and is the same mechanism by which known carcinogens like tobacco smoke and UV radiation promote malignancy.
The oxidative stress pathway is particularly concerning for nanoplastics, which are small enough to cross cellular membranes and accumulate inside cells. While larger microplastics may cause inflammation from outside the cell, nanoplastics can cause damage from within, directly interacting with the cell’s genetic material.
3. Endocrine Disruption and Hormone-Sensitive Cancers
Many plastic polymers contain or leach chemicals that act as endocrine disruptors — substances that mimic, block, or interfere with the body’s hormones. The most well-studied of these is bisphenol A (BPA), a component of polycarbonate plastics and epoxy resins, but the list also includes phthalates, bisphenol S (BPS), nonylphenol, and numerous other compounds.
BPA has been classified as a possible carcinogen (Group 2A) by the European Chemicals Agency, and its effects on hormone-sensitive cancers are extensively documented. BPA mimics estrogen by binding to estrogen receptors, and chronic exposure has been linked to increased risk of breast cancer, prostate cancer, and ovarian cancer in both animal models and epidemiological studies.
A 2023 meta-analysis published in Environmental Research reviewed 42 studies on BPA exposure and cancer outcomes and found a statistically significant positive association between higher BPA exposure (measured through urinary BPA levels) and breast cancer incidence. The effect was most pronounced in premenopausal women, suggesting that BPA’s estrogenic activity interacts with natural hormonal cycles to promote tumor development.
Importantly, endocrine-disrupting chemicals can exert biological effects at extremely low concentrations — parts per billion or even parts per trillion. This means that even the small amounts of BPA, phthalates, and other additives that leach from microplastic particles as they degrade inside the body may be sufficient to disrupt hormonal signaling and promote cancer growth over time.
4. Microplastics as Carriers of Known Carcinogens
One of the most underappreciated risks of microplastics is their ability to act as “Trojan horses” for other toxic and carcinogenic substances. The hydrophobic surface of plastic particles attracts and concentrates persistent organic pollutants (POPs), polycyclic aromatic hydrocarbons (PAHs), heavy metals, and other environmental contaminants.
Studies have shown that microplastics in the environment can concentrate pollutants at levels up to one million times higher than the surrounding water or soil. When these contaminated particles are ingested, the toxic chemicals can desorb from the plastic surface in the warm, acidic environment of the digestive system and be absorbed into the body at concentrations far higher than they would be from water or food alone.
PAHs are a class of chemicals formed during incomplete combustion of organic matter and are classified as known or probable carcinogens by the International Agency for Research on Cancer (IARC). Heavy metals like cadmium, lead, and mercury — all found adsorbed to environmental microplastics — are also established or suspected carcinogens. The combination of microplastic particles carrying these toxic payloads directly into human tissues represents a novel exposure pathway that did not exist before the age of plastic pollution.
Which Types of Plastic Are Most Concerning for Cancer Risk?
Not all plastics carry the same level of cancer risk. The chemical composition of the polymer, the additives used during manufacturing, and the degradation products formed as the plastic breaks down all influence carcinogenic potential.
Polyvinyl Chloride (PVC) — Type 3
PVC is widely regarded as the most toxic common plastic. Its production involves vinyl chloride monomer, a known human carcinogen (IARC Group 1) that causes liver angiosarcoma, a rare and aggressive cancer. PVC products also contain high levels of phthalate plasticizers, many of which are endocrine disruptors. PVC is used in food packaging, water pipes, cling wrap, and countless other products. The NEJM study found PVC in the arterial plaque of 12.1% of patients.
Polystyrene (PS) — Type 6
Polystyrene is made from styrene monomer, which is classified as a probable human carcinogen (IARC Group 2A). Styrene has been linked to lymphatic and hematopoietic cancers (leukemia and lymphoma) in occupational studies of workers exposed to styrene in manufacturing settings. Polystyrene is commonly found in foam food containers, disposable cups, and packaging materials. It readily breaks down into microplastic particles when exposed to heat and UV light.
Polycarbonate (PC) — Type 7
Polycarbonate plastics are made with BPA, the endocrine disruptor linked to breast, prostate, and ovarian cancers. Despite growing awareness of BPA risks, polycarbonate is still used in water bottles, food storage containers, and dental sealants. Products labeled “BPA-free” often substitute BPS or BPF, which have shown similar estrogenic activity in laboratory studies.
Polyethylene (PE) and Polypropylene (PP) — Types 2, 4, and 5
Polyethylene and polypropylene are generally considered lower-risk plastics in terms of chemical leaching, and they do not contain BPA or styrene. However, they still generate inflammatory responses when particles lodge in tissues, and they still act as carriers for environmental contaminants. The NEJM study found polyethylene in the arterial plaque of 58.4% of patients, and its presence was associated with significantly worse cardiovascular outcomes. Even “safer” plastics become hazardous when fragmented into micro and nanoparticles that accumulate in the body.
Microplastics and Specific Cancer Types
Colorectal Cancer
The gastrointestinal tract is the primary entry point for ingested microplastics, and the colon is where the longest contact time occurs. A 2024 study from Zhejiang University found that patients with colorectal cancer had significantly higher concentrations of microplastics in their tumor tissue compared to adjacent healthy tissue. The researchers identified polypropylene, polyethylene, and polyester as the most common polymers. While this does not prove causation, the accumulation of microplastics specifically in cancerous tissue is consistent with the chronic inflammation and oxidative stress mechanisms discussed above.
The rising incidence of colorectal cancer in adults under 50 — a trend that has puzzled epidemiologists for over a decade — has led some researchers to hypothesize that increased microplastic exposure may be a contributing factor. Adults born after 1960 have been exposed to vastly more plastic throughout their lifetimes than previous generations, and the timing of the colorectal cancer increase aligns with the exponential growth in plastic production and microplastic environmental contamination.
Lung Cancer
Airborne microplastics are inhaled with every breath. A 2022 study published in Science of the Total Environment detected microplastic particles in 11 of 13 human lung tissue samples examined. The most common particles found were polypropylene and PET. The lung tissue microenvironment, where foreign particles trigger persistent inflammatory responses, is well-known as a site where chronic irritation can lead to malignancy — the same mechanism by which asbestos causes mesothelioma.
Animal studies support this concern. Mice exposed to inhaled polystyrene microplastics for 28 days developed significant lung inflammation, alveolar damage, and elevated levels of the tumor marker protein Ki-67, which indicates increased cellular proliferation — a precursor to tumor formation. Long-term inhalation studies are ongoing, but the early evidence suggests that airborne microplastics may represent an underappreciated risk factor for lung cancer.
Breast and Prostate Cancer
The endocrine-disrupting chemicals associated with certain plastics have the strongest established links to hormone-sensitive cancers. BPA exposure has been consistently associated with increased breast cancer risk in epidemiological studies, and animal studies have shown that prenatal BPA exposure can alter mammary gland development in ways that increase susceptibility to breast cancer later in life. Similarly, phthalate exposure has been linked to prostate cancer progression through androgen receptor interference.
What the Science Does and Does Not Tell Us
It is essential to be precise about the current state of scientific knowledge. Here is what we know and what remains uncertain:
What the evidence supports:
- Microplastics accumulate in human tissues and organs, including arterial plaque, lungs, liver, kidneys, placenta, and brain tissue.
- The presence of microplastics in arterial plaque is associated with a 4.53x higher risk of major adverse cardiovascular events and death (NEJM 2024).
- Microplastics cause chronic inflammation, oxidative stress, and DNA damage in cell culture and animal studies — all established mechanisms of cancer development.
- Specific plastic chemicals (vinyl chloride, styrene, BPA) are classified as known or probable carcinogens by IARC.
- Microplastics concentrate and deliver environmental carcinogens (PAHs, heavy metals) into the body.
What remains uncertain:
- No long-term prospective human study has yet directly demonstrated that microplastic exposure causes cancer in humans.
- The threshold dose at which microplastic exposure becomes clinically significant for cancer risk is unknown.
- The relative contribution of microplastics versus other environmental and lifestyle factors to cancer incidence has not been quantified.
- Whether the body can eventually clear accumulated microplastics, or whether they persist indefinitely, is not fully understood.
The scientific consensus is moving toward recognition that microplastic exposure poses real health risks, but the specific cancer-related risks will take years or decades of epidemiological research to fully quantify. In the meantime, the precautionary principle suggests that reducing exposure is prudent.
How to Reduce Your Microplastic Exposure and Cancer Risk
While you cannot eliminate microplastic exposure entirely in the modern world, you can significantly reduce it through practical lifestyle changes:
Minimize Plastic Food Contact
Never heat food in plastic containers — use glass, ceramic, or stainless steel instead. Avoid plastic wrap on hot food. Replace plastic food storage with glass containers. The combination of heat and plastic is the single largest source of dietary microplastic exposure you can directly control.
Filter Your Water
Use a reverse osmosis or activated carbon block filtration system to remove microplastics from your drinking and cooking water. Avoid single-use plastic water bottles, which contain some of the highest concentrations of nanoplastics ever measured in consumer products — up to 240,000 particles per liter.
Choose Fresh Over Processed and Packaged
Highly processed foods that undergo multiple manufacturing steps in plastic equipment and are stored in plastic packaging contain more microplastics than fresh, minimally processed foods. Buying fresh produce, cooking from scratch, and storing food in glass or metal containers reduces exposure across your entire diet.
Reduce Airborne Exposure
Synthetic textiles shed microplastic fibers into indoor air. Using a HEPA air purifier, wet mopping instead of dry sweeping, choosing natural-fiber clothing when possible, and ensuring good ventilation can reduce the microplastics you inhale at home and work.
Be Informed About What You Buy
Not all products carry the same microplastic risk. Understanding which products, brands, and packaging materials contribute the most to your exposure allows you to make targeted substitutions where they matter most. This is exactly where product scanning tools become invaluable.
Frequently Asked Questions
Do microplastics cause cancer?
The evidence is still emerging, and no study has yet proven a direct causal link between microplastic ingestion and cancer in humans. However, microplastics have been shown to cause chronic inflammation, oxidative stress, DNA damage, and endocrine disruption in laboratory and animal studies — all of which are established mechanisms that promote cancer development. Some plastic-associated chemicals like vinyl chloride and BPA are classified as known or probable carcinogens.
What did the 2024 NEJM study find about microplastics?
The landmark 2024 New England Journal of Medicine study found that 58.4% of patients had polyethylene microplastics in their carotid artery plaque. Patients with microplastics in their plaque had a 4.53 times higher risk of heart attack, stroke, or death over 34 months. The study also found elevated inflammatory markers associated with the microplastic presence, which has implications for cancer risk.
Which plastics are the most carcinogenic?
PVC (polyvinyl chloride, type 3) is considered the most dangerous, as its production involves vinyl chloride, a known human carcinogen. Polystyrene (type 6) contains styrene, a probable carcinogen. Polycarbonate (type 7) contains BPA, an endocrine disruptor linked to breast and prostate cancer. Even plastics considered “safer” like polyethylene cause inflammatory responses when they accumulate as microparticles in tissue.
Can microplastics carry other cancer-causing chemicals?
Yes. Microplastics act as carriers for persistent organic pollutants, PAHs, and heavy metals, concentrating these substances at levels up to one million times higher than the surrounding environment. When ingested, these toxins can desorb from the plastic surface inside the body, delivering concentrated doses of known carcinogens directly to tissues.
How can I reduce my cancer risk from microplastics?
The most impactful steps are: never heat food in plastic containers, filter your drinking water with a reverse osmosis system, choose fresh foods over heavily packaged processed foods, use glass or stainless steel for food storage and cooking, and reduce airborne microplastic exposure with a HEPA air purifier. You can also use the MicroPlastics app to scan products and identify which ones carry the highest microplastic risk.
Check Your Products with the MicroPlastics App
Scan any product to instantly see its microplastic risk level. Start with 5 free scans.
Download Free on iOSStart Scanning Your Products Today
Download the MicroPlastics app and instantly check any product for microplastic content. Free to start with 5 scans.
Download for iOS